Phase 3 study of Reparixin for Treatment of Hospitalized Patients With COVID-19 Pneumonia
Latest Information Update: 17 Jun 2022
At a glance
- Drugs Reparixin (Primary)
- Indications COVID 2019 infections; COVID-19 pneumonia
- Focus Therapeutic Use
Most Recent Events
- 17 Jun 2022 New trial record
- 13 Jun 2022 According to a Dompe Farmaceutici media release, the company will conduct this study to confirm the results from phase 2 study.